跳至主要内容
临床试验/KCT0004599
KCT0004599招募中未知

Recurrence free survival after hepatectomy using propofol-based anesthesia and sevoflurane-based anesthesia: a randomized controlled study

Samsung Medical Center0 个研究点目标入组 536 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中
入组人数
536

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
18(Year) 至 75(Year)(—)
性别
All

入选标准

  • Adults who undergo elective hepatectomy for hepatocellular carcinoma
  • (older than 18 years old and younger than 76 years old)
  • -American society of anesthesia (ASA) class I-III
  • -Patients who have agreed to the trial and signed the subject's consent

排除标准

  • - Patients with who have history of side effects from the use of the anesthetic or have contraindication for drugs (a patient suspected of having an allergic reaction to the drug)
  • - Patients who have liver cancer other than hepatocellular carcinoma (eg Cholangiocarcinoma or metastatic liver tumor)
  • - Patients who is deemed inappropriate to participate in the clinical trial by the researcher's judgment
  • - Patients who are allergic to nuts or beans
  • - Patients who have a history of malignant hyperthermia or risk factors of malignant hyperthermia
  • - Patients who underwent interventional procedure for HCC
  • - Patients who have elevated intracranial hypertension
  • - Patients who have distant metastasis to other organ
  • - Patients who undergo ALPS (Associating liver partition and portal vein ligation for staged hepatectomy)

研究者

相似试验